Pargluva muraglitazar regulatory update

FDA's Endocrinologic and Metabolic Drugs Advisory Committee recommended approval of Pargluva muraglitazar to treat Type II diabetes. If approved, Pargluva would be the first dual PPAR alpha and gamma...